Skip to main content

Table 1 Survival time and sizes of PC-9-Br tumors based on drug treatment

From: Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis

TherapynSurvival (days)Median size (mm2)IQR (mm2)
Vehicle114420.18440.1129–0.3097
Cisplatin+Pemetrexed9645a0.2492a0.1305–0.4054
Cisplatin+Etoposide11751.5b,c0.1093b,c0.0533–0.2384
  1. Values bearing the letter a indicate no significant differences compared with vehicle, those labeled b denote a significant difference when compared with vehicle, and c denotes a significant difference when is cisplatin+etoposide compared with cisplatin+pemetrexed